The reported milder phenotype of double LRRK2 and GBA1 variant carriers vs. GBA-PD further complicates this interrelationship but at the same time, provides additional evidence for bidirectional modulation and potential for broader use of specifically targeted therapeutics. Here, LRRK2 is linked to Parkinson disease.